These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25658256)

  • 1. Pivotal trials for β-secretase inhibitors in Alzheimer's.
    Sheridan C
    Nat Biotechnol; 2015 Feb; 33(2):115-6. PubMed ID: 25658256
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatments for Alzheimer's disease emerge.
    Selkoe DJ
    Science; 2021 Aug; 373(6555):624-626. PubMed ID: 34353940
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?
    Imbimbo BP; Panza F; Frisardi V; Solfrizzi V; D'Onofrio G; Logroscino G; Seripa D; Pilotto A
    Expert Opin Investig Drugs; 2011 Mar; 20(3):325-41. PubMed ID: 21222550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating transgenic Alzheimer mice with a β-secretase inhibitor, what have we learned?
    Tang J; Ghosh A
    Aging (Albany NY); 2011 Jan; 3(1):14-6. PubMed ID: 21248377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
    Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deal watch: Lilly buys back into the BACE race for Alzheimer's disease.
    Cully M
    Nat Rev Drug Discov; 2014 Nov; 13(11):804. PubMed ID: 25323931
    [No Abstract]   [Full Text] [Related]  

  • 7. Are γ-secretase inhibitors detrimental for Alzheimer's disease patients?
    Ross JS; Imbimbo BP
    J Alzheimers Dis; 2010; 22(2):401-4. PubMed ID: 21149978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-secretase inhibitors for Alzheimer's disease: heading in the wrong direction?
    Selkoe D
    Lancet Neurol; 2019 Jul; 18(7):624-626. PubMed ID: 31202466
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease and other dementias: update on research.
    Schneider L
    Lancet Neurol; 2017 Jan; 16(1):4-5. PubMed ID: 27979354
    [No Abstract]   [Full Text] [Related]  

  • 10. Disease modifying drugs targeting β-amyloid.
    Ozudogru SN; Lippa CF
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):296-300. PubMed ID: 22815077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Secretase as a target for Alzheimer's disease.
    Wolfe MS
    Adv Pharmacol; 2012; 64():127-53. PubMed ID: 22840746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of gamma-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease.
    Asberom T; Zhao Z; Bara TA; Clader JW; Greenlee WJ; Hyde LA; Josien HB; Li W; McPhail AT; Nomeir AA; Parker EM; Rajagopalan M; Song L; Wong GT; Zhang L; Zhang Q; Pissarnitski DA
    Bioorg Med Chem Lett; 2007 Jan; 17(2):511-6. PubMed ID: 17079141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-secretase modulators: hopes and setbacks for the future of Alzheimer's treatment.
    Evin G
    Expert Rev Neurother; 2008 Nov; 8(11):1611-3. PubMed ID: 18986229
    [No Abstract]   [Full Text] [Related]  

  • 14. Alzheimer's disease. The secret may be secretase.
    Harv Health Lett; 2000 Jan; 25(3):5. PubMed ID: 10594956
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent advances in Alzheimer's disease-related gamma-secretase complex].
    Tomita T; Iwatsubo T
    Seikagaku; 2004 Jul; 76(7):666-70. PubMed ID: 15346905
    [No Abstract]   [Full Text] [Related]  

  • 16. Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
    Zhao Z; Pissarnitski DA; Josien HB; Bara TA; Clader JW; Li H; McBriar MD; Rajagopalan M; Xu R; Terracina G; Hyde L; Song L; Zhang L; Parker EM; Osterman R; Buevich AV
    Eur J Med Chem; 2016 Nov; 124():36-48. PubMed ID: 27560281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease.
    Silvestri R
    Med Res Rev; 2009 Mar; 29(2):295-338. PubMed ID: 18651582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gamma-secretase inhibitors in Alzheimer's disease therapy].
    Katarína S; Jan K; Kamil K; Kamil M
    Ceska Slov Farm; 2012 Jun; 61(3):93-100. PubMed ID: 22913824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Alzheimer's disease drug discovery: an update.
    Williams M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.